SEK

Business

Hansa Biopharma reports robust Q4 with SEK 50m revenue By Investing.com

© Reuters. LUND, Sweden – Hansa Biopharma, a leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced a business…

Read More »
Back to top button